ROANOKE, Va. (WDBJ) - There has been a notable decrease in prescriptions for benzodiazepine drugs, a category that includes Xanax, Valium, Ativan, and Klonopin, across the United States. A study conducted by Rutgers Health revealed a 26% decline in prescriptions from 2013 to 2024. The authors of the study suggest that this trend indicates a more cautious prescribing approach by doctors due to concerns about the medications' potential contribution to overdose deaths.
Read More
Additionally, a European study reported promising developments regarding the use of GLP-1 drugs for children with type 2 diabetes. The research found that over a third of the young participants who were treated with these medications experienced a reduction of more than 5% in their body mass index, while one in four lost at least 10%. This could offer a new avenue for children with obesity who have struggled to achieve weight loss through lifestyle changes alone.
Further, researchers from NYU Langone Health have identified a potential risk associated with consuming sweets while on antibiotics. Their findings indicate that antibiotics can diminish healthy gut bacteria, and excessive sugar intake exacerbates this harm, compromising gut health and the immune system's ability to function effectively.